Clinical Addiction Psychiatry

269 Pages·2010·3.12 MB·English

by  David Brizer MD

This page intentionally left blank
Clinical Addiction Psychiatry

Clinical Addiction Psychiatry
Edited by
David Brizer and Ricardo Castaneda
CAMBRIDGEUNIVERSITYPRESS
Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore,
São Paulo, Delhi, Dubai, Tokyo
Cambridge University Press
The Edinburgh Building, Cambridge CB2 8RU, UK
Published in the United States of America by Cambridge University Press, New York
www.cambridge.org
Information on this title: www.cambridge.org/9780521899581
© Cambridge University Press 2010
This publication is in copyright. Subject to statutory exception and to the
provision of relevant collective licensing agreements, no reproduction of any part
may take place without the written permission of Cambridge University Press.
First published in print format 2010
ISBN-13 978-0-521-89958-1 Hardback
Cambridge University Press has no responsibility for the persistence or accuracy
of urls for external or third-party internet websites referred to in this publication,
and does not guarantee that any content on such websites is, or will remain,
accurate or appropriate.
Every effort has been made in preparing this book to provide accurate and up-to-
date information which is in accord with accepted standards and practice at the
time of publication. Although case histories are drawn from actual cases, every
effort has been made to disguise the identities of the individuals involved.
Nevertheless, the authors, editors and publishers can make no warranties that the
information contained herein is totally free from error, not least because clinical
standards are constantly changing through research and regulation. The authors,
editors and publishers therefore disclaim all liability for direct or consequential
damages resulting from the use of material contained in this book. Readers are
strongly advised to pay careful attention to information provided by the
manufacturer of any drugs or equipment that they plan to use.
Contents
Contributors vii
Preface ix
Part 1 – Theory 12 Alcoholism 102
Jerome Levin
1 Death, drugs, and rock & roll 3
13 Alcoholism in primary care 125
David Brizer
Mack Lipkin, Andrea Truncali & Joshua D. Lee
2 The disease concept – controversies
14 Nicotine addiction and smoking cessation 133
and integration 12
Neil Hartman
Mark Schenker
15 Clinical aspects of cocaine and
3 Medical sequelae of addiction 24
methamphetamine dependence 137
Michael Weaver
Arnold Washton
4 Suicide and substance abuse 37
16 Methadone treatment 147
Samoon Ahmad
Robert Maslansky
5 Abstinence as a goal 45 17 Psychoactive prescription drug abuse 154
Laurence M. Westreich Bernard Salzman & Peter Micheels
6 Ibogaine therapy for substance abuse
disorders 50 Part 3 – Praxis
Deborah C. Mash
18 Pain management and addiction
7 Therapeutic communities in the new
treatment 163
millennium 61
Robert Maslansky
George De Leon
19 EEG neurofeedback therapy 169
8 Cosmetic psychopharmacology: drugs
Siegfried Othmer & Mark Steinberg
that enhance wellbeing, performance,
20 The new pharmacotherapies for alcohol
and creativity 72
dependence 188
Richard N. Rosenthal & Laurence M. Westreich
Barbara J. Mason & Marni Jacobs
9 Psychotherapeutic paradigms and the
21 Dialectical behavior therapy adapted to the
prescription pad: treating drug addiction
treatment of concurrent borderline personality
with drugs 88
disorder and substance use disorders 207
Ed Paul
Lisa Burckell & Shelley McMain
10 Six key areas when working
22 Addiction and emergency psychiatry 218
with addicts 92
Richard Gallagher, Gregory Fernandez
Kathleen Tracy
& Edward Lulo
23 Ear acupuncture in addiction treatment 230
Part 2 – Real World
Michael Smith
11 The twelve-step approach 97
Marc Galanter Index 251
v

Contributors
Samoon Ahmad, MD Mack Lipkin
Bellevue-NYU Medical Center, New York, NY, USA New York University School of Medicine, New York,
NY, USA
David Brizer, MD
Mind-Meds.com, Nyack, NY, USA Edward Lulo, MD
Psychiatrist, Danbury, CT, USA
Lisa Burkell
University of Toronto, Toronto, Ontario, Canada Shelley McMain, PhD
Centre for Addiction and Mental Health,
Ricardo Castaneda, MD
Department of Psychiatry, University of Toronto,
New York University School of Medicine, New York,
Toronto, Ontario, Canada
NY, USA
Deborah C. Mash, PhD
George De Leon, MD
University of Miami Medical Center, Miami, FL, USA
National Development and Research Institutes,
New York, NY, USA Robert Maslansky, MD
Bellevue-NYU Medical Center, New York, NY, USA
Gregory Fernandez
Westchester Medical Center, Valhalla, NY, USA Barbara J. Mason, PhD
Scripps Institute, La Jolla, CA, USA
Marc Galanter, MD
Professor of Psychiatry, New York University School Peter Micheels, MD
of Medicine, New York, NY, USA; Research Scientist, Bellevue-NYU Medical Center, New York, NY, USA
Nathan Kline Institute for Psychiatric Research
Siegfried Othmer, PhD
Richard Gallagher, MD Mark Steinberg, PhD and Associates, Los Gatos,
Department of Psychiatry, Westchester Medical CA, USA
Center, Valhalla, NY, USA
Ed Paul, MD
Neil Hartman, MD New York, NY, USA
VA Medical Center, Los Angeles, CA, USA
Richard N. Rosenthal, MD
Marni Jacobs, MPH Bellevue-NYU Medical Center, New York, NY, USA
Scripps Institute, La Jolla, CA, USA
Bernard Salzman, MD
Joshua D. Lee, MD Msc Bellevue-NYU Medical Center, New York, NY, USA
New York University School of Medicine, New York,
Mark Schenker, PhD
NY, USA
Caron Treatment Centers, New York, NY, USA
Jerome Levin, PhD
Michael Smith, MD
The New School, New York, NY, USA
Lincoln Hospital Medical Center, Bronx, NY, USA
vii
Contributors
Mark Steinberg, PhD Arnold Washton, PhD
Mark Steinberg, PhD and Associates, Los Gatos, CA, Recovery Options, New York, NY, USA
USA
Michael Weaver, MD
Kathleen Tracy, MD Virginia Commonwealth University, Richmond,
Bellevue-NYU Medical Center, New York, NY, USA VA, USA
Andrea Truncali, MD MPH Lawrence M. Westreich, MD
New York University School of Medicine, New York, Bellevue-NYU Medical Center, New York,
NY, USA NY, USA
viii